Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era - «Национальный агрегатор открытых репозиториев российских университетов» (НОРА)

Материалов:
678 583

Репозиториев:
29

Авторов:
475 470

расширенный поиск

Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era

Дата публикации: 2021-04-27

Дата публикации в реестре: 2021-10-05T18:36:44Z

Ключевые слова:
amoxicillin, aspartate aminotransferase, azithromycin, C reactive protein, cefamandole, ceftazidime, ceftriaxone, corticosteroid, creatinine, D dimer, fibrinogen, globulin, levofloxacin, low molecular weight heparin, methylprednisolone, piperacillin, procalcitonin, sulbactam, anticoagulant agent, low molecular weight heparin, activated partial thromboplastin time, adult, adult respiratory distress syndrome, aged, anticoagulant therapy, anticoagulation, cohort analysis, controlled study, coronavirus disease 2019, disease severity, drug use, epidemic, female, fibrinogen blood level, gastrointestinal hemorrhage, hospital admission, human, human cell, incidence, invasive ventilation, Letter, leukocyte count, lymphocyte count, major clinical study, male, middle aged, mortality, mortality risk, noninvasive ventilation, observational study, oxygen therapy, priority journal, prophylaxis, prothrombin time, Sequential Organ Failure Assessment Score, sex difference, survival, bleeding, blood, China, drug therapy, epidemiology, hospital mortality, hospitalization, mortality, risk factor, time factor, treatment outcome, very elderly, Adult, Aged, Aged, 80 and over, Anticoagulants, China, COVID-19, Female, Hemorrhage, Heparin, Low-Molecular-Weight, Hospital Mortality, Hospitalization, Humans, Male, Middle Aged, Risk Factors, Time Factors, Treatment Outcome

Тип: info:eu-repo/semantics/journal-article

Связанные документы (рекомендация CORE)